R. Pryor

Most-cited papers

1. Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation

   T. Seldon, R. Pryor, A. Palkova, Martina L. Jones +18 more

   2016Leukemia31 citations

   Semantic Scholar

   Save

2. A comparison of treatment outcomes for moxifloxacin versus ofloxacin/metronidazole for first-line treatment of uncomplicated non-gonococcal pelvic inflammatory disease

   M. Boothby, J. Page, R. Pryor, J. Ross

   2010International Journal of STD and AIDS12 citations

   Semantic Scholar

   Save

3. A single 1 g/kg dose of intravenous immunoglobulin is a safe and effective treatment for immune thrombocytopenia; results of the first HaemSTAR ‘Flash‐Mob’ retrospective study incorporating 961 patients

   Phillip L. R. Nicolson, R. Perry, R. Buka, Amelia Fisher +134 more

   2021British Journal of Haematology10 citations Open access

   Semantic Scholar

   Save

4. A HaemSTAR-led, UK-wide 'flash-mob' audit of -intravenous immunoglobulin use in immune -thrombocytopenia.

   P. Nicolson, R. Perry, Amelia Fisher, Gemma Scott +132 more

   2019Clinical medicine (London)3 citations Open access

   Semantic Scholar

   Save

5. 12-Month Full Donor Chimerism Is Associated with Low-Grade Acute Graft Versus Host Disease (aGVHD) and Predicts Superior Outcomes in Reduced Intensity (RIC) Alemtuzumab-Based Transplants for MDS and AML

   A. Kanellopoulos, S. Paneesha, Evgenia Xenou, I. Qureshi +15 more

   20160 citations

   Semantic Scholar

   Save

6. Efficacy and Safety of Melphalan 140mg/m2 Conditioned Autologous Stem Cell Transplantation in Elderly Pre-Dialysis and Dialysis Patients with Multiple Myeloma

   Hatem Ali, B. Jyoti, S. Paneesha, R. Lovell +9 more

   20160 citations

   Semantic Scholar

   Save